Home > Insider Trading > Filing (0001628280-25-034531)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1357874	Precision Biosciences Inc	DTIL	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1590030	Alexander John Kelly	C/O Precision Biosciences, Inc. 302 E. Pettigrew Street, Suite A-100 Durham NC 27701	Chief Financial Officer	No	Yes	No	No

Transaction Summary

Sold:	14,827 shares	Avg. Price: $4.26	Total Value: $63,163.02
Number of Shares After Transactions:	73,485 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-07-03	14,827	$4.26	73,485	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales were effected pursuant to a Rule 10b5-1 plan adopted on January 17, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the settlement of 44,368 RSUs which vested on January 20, 2025. The settlement occurred on July 3, 2025, as approved by the Issuer's Compensation Committee. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
Includes 2,056 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a weighted average price of $7.21.